M. Yano

发表

Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo

N. Nagai, K. Okada, O. Matsuo, 2012, Thrombosis and Haemostasis.

ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.

S. Oparil, Yunjia Chen, M. Yano, 1995, The American journal of physiology.

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

T. Fukami, M. Yano, T. Saeki, 1992, Life sciences.

Increased Expression of Endothelin B Receptor mRNA following Subarachnoid Hemorrhage in Monkeys

R. Macdonald, G. Bell, R. Macdonald, 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Two endothelin receptor subtypes in porcine arteries.

M. Yano, T. Saeki, T. Fukuroda, 1991, Journal of cardiovascular pharmacology.

Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.

S. Oparil, T. Elton, Yiu-fai Chen, 1995, The American journal of physiology.

Stimulation of rat liver growth by a 1,3-dithiole derivative, KZ-1026.

M. Yano, S. Tsuchida, K. Matsushima, 1989, Japanese journal of pharmacology.

A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.

Y. Sawasaki, A. Hisaka, M. Yano, 1989, Journal of pharmaceutical sciences.

Hydrolysis and acyl migration of a catechol monoester of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.

A. Hisaka, M. Yano, K. Kitani, 1990, Journal of pharmaceutical sciences.

Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model.

M. Yano, T. Fukuroda, K. Ishikawa, 1993, Life sciences.

Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.

Y. Sugishita, I. Yamaguchi, T. Miyauchi, 1993, Circulation research.

EFFECTS OF A SELECTIVE ENDOTHELIN A‐RECEPTOR ANTAGONIST, BQ‐123, IN SALT‐LOADED STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS

M. Yano, Masahiko Kobayashi, M. Kobayashi, 1995, Clinical and Experimental Pharmacology and Physiology.

Cardiovascular and Renal Actions of the Endothelinb Receptor in Pigs

E. Martin, M. Yano, I. Rodger, 1997 .

Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.

T. Nakamura, Y. Sawasaki, A. Hisaka, 1996, The Journal of pharmacology and experimental therapeutics.

A novel ETA antagonist (BQ‐123) inhibits endothelin‐1‐induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells

Y. Hirata, F. Marumo, S. Eguchi, 1992, FEBS letters.

Endothelin-1 contributes to antigen-induced airway hyperresponsiveness.

W. Abraham, M. Yano, K. Noguchi, 1995, Journal of applied physiology.

Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action

R. Couture, M. Yano, J. Champlain, 1994, Brain Research.

Endothelin receptor subtypes in human versus rabbit pulmonary arteries.

Y. Sugishita, T. Miyauchi, K. Goto, 1994, Journal of applied physiology.

BQ123, an ETA Receptor Antagonist, Attenuates Endothelin‐1-Induced Vasoconstriction in Rat Pulmonary Circulation

M. Zamora, M. Oka, T. Stelzner, 1993, Journal of cardiovascular pharmacology.

A novel ligand, [125I]BQ-3020, reveals the localization of endothelin ETB receptors.

S. Ozaki, M. Yano, T. Saeki, 1993, European journal of pharmacology.

Local formation and degradation of endothelin-1 in guinea pig airway tissues.

K. Matsuyama, Y. Tsukada, Y. Ikeno, 1991, Biochemical and biophysical research communications.

Synergistic inhibition by BQ‐123 and BQ‐788 of endothelin‐1‐induced contractions of the rabbit pulmonary artery

S. Ozaki, M. Yano, T. Fukuroda, 1994, British journal of pharmacology.

Progression of Cardiopulmonary Alterations in Rats With Monocrotaline-Induced Pulmonary Hypertension

Iwao, Y. Sugishita, T. Miyauchi, 2005 .

Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153.

T. Fukami, M. Yano, Y. Ohta, 1992, Life sciences.

Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin‐1‐induced contraction in human bronchi

S. Ishikawa, T. Miyauchi, K. Goto, 1996, British journal of pharmacology.

Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1.

M. Yano, T. Saeki, M. Kobayashi, 1992, Biochemical and biophysical research communications.

ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells.

S. Ozaki, M. Yano, T. Fukuroda, 1995, Biochemical and biophysical research communications.

Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors.

S. Ozaki, M. Yano, M. Ihara, 1997, Journal of biochemistry.

Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.

A. Nakajima, M. Yano, M. Kobayashi, 1992, European journal of pharmacology.

A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors.

S. Ozaki, M. Yano, T. Saeki, 1992, Life sciences.

Endothelin converting enzyme of bovine carotid artery smooth muscles.

K. Okada, K. Matsuyama, M. Yano, 1991, Biochemical and biophysical research communications.

Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells.

K. Okada, K. Matsuyama, M. Yano, 1990, Biochemical and biophysical research communications.

Hyperresponsiveness to ET‐1 After Treatment with a Mixture of ETA and ETB Receptor Antagonists in the Rabbit In Vivo and In Vitro

J. Gratton, M. Yano, P. D'Orléans-Juste, 1995, Journal of cardiovascular pharmacology.

Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor.

A. Fournier, J. Filep, M. Yano, 1992, European Journal of Pharmacology.

Big endothelin-1 structure important for specific processing by endothelin-converting enzyme of bovine endothelial cells.

K. Okada, K. Matsuyama, M. Yano, 1993, European journal of biochemistry.

Block of Endothelin‐1‐induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ‐788

J. Gratton, M. Yano, A. Claing, 1994, British journal of pharmacology.

Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells.

K. Okada, K. Matsuyama, M. Yano, 1991, Biochemical and Biophysical Research Communications - BBRC.

Suppressive effects of the endothelin receptor (ETA) antagonist BQ-123 on ET-1-induced reduction of lipoprotein lipase activity in 3T3-L1 adipocytes.

M. Yano, T. Saeki, T. Kamei, 1992, Biochemical pharmacology.

Synthesis of 2-substituted d-tryptophan-containing peptide derivatives with endothelin receptor antagonist activity

T. Fukami, M. Yano, M. Ihara, 1995 .

The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.

M. Yano, T. Sasaki, M. Kobayashi, 1995, European journal of pharmacology.

Localization and Alteration of Immunoreactive Endothelin-1 in Canine Basilar Arteries Following Subarachnoid Hemorrhage

Tomio Sasaki, M. Yano, Masahiko Kobayashi, 1995 .

Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt.

M. Yano, T. Fukuroda, F. Ikemoto, 1994, European journal of pharmacology.

Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon

T. Hayama, K. Matsuyama, T. Fukami, 1994 .

Role of endothelin ETB receptors in bronchoconstrictor and vasoconstrictor responses in guinea-pigs.

M. Yano, K. Noguchi, M. Ihara, 1993, European journal of pharmacology.

BQ‐153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin‐1

A. Ford-hutchinson, M. Yano, J. Maw, 1992, The Journal of pharmacy and pharmacology.

Biochemical properties of endothelin converting enzyme in renal epithelial cell lines.

K. Okada, K. Matsuyama, M. Yano, 1992, Biochemical and biophysical research communications.

Endothelin-binding inhibitors, BE-18257A and BE-18257B. I. Taxonomy, fermentation, isolation and characterization.

H. Suda, M. Yano, M. Ihara, 1991, Journal of antibiotics (Tokyo. 1968).

Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme.

K. Okada, K. Matsuyama, M. Yano, 1991, Biochemical and biophysical research communications.

CORONARY VASCULAR RESPONSE TO ENDOTHELIN IN ISOLATED PERFUSED HEARTS OF SPONTANEOUSLY HYPERTENSIVE RATS

H. Takeshita, M. Yano, F. Ikemoto, 1991, Clinical and experimental pharmacology & physiology.

Inhibition of biological actions of big endothelin-1 by phosphoramidon.

K. Okada, M. Yano, K. Noguchi, 1990, Biochemical and biophysical research communications.

Cyclic pentapeptide endothelin antagonists with high ETA selectivity. Potency- and solubility-enhancing modifications.

T. Hayama, T. Fukami, M. Yano, 1992, Journal of medicinal chemistry.

Influence of endothelin ETA and ETB receptor antagonists on endothelin-induced contractions of the guinea pig isolated gall bladder

M. Yano, G. Rae, P. D'Orléans-Juste, 1997, Regulatory Peptides.

Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.

S. Ozaki, T. Fukami, M. Yano, 1996, Journal of medicinal chemistry.

Endothelin antagonistic peptide derivatives with high selectivity for ETA receptors

T. Hayama, T. Fukami, M. Yano, 1993 .

Evidence for atypical endothelin receptors and for presence of endothelin-converting enzyme activity in the mouse isolated vas deferens.

M. Yano, G. Rae, P. D'Orléans-Juste, 1995, European journal of pharmacology.

Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.

K. Okada, M. Yano, H. Hattori, 1988, European journal of biochemistry.

Endothelin Receptor Antagonists with Various Subtype-Specificity: Their Discovery and Use as Pharmacological Tools

T. Hayama, S. Ozaki, T. Fukami, 1995, European Journal of Medicinal Chemistry.

Stimulation of DNA Synthesis in Adult Rat Hepatocytes in Primary Culture by a New Hepatocyte Growth Accelerator: KZ-1026

S. Jinno, M. Yano, Y. Monden, 1989 .

Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.

S. Ozaki, T. Fukami, M. Yano, 1994, The Journal of pharmacology and experimental therapeutics.

Clearance of circulating endothelin-1 by ETB receptors in rats.

S. Ozaki, M. Yano, T. Fujikawa, 1994, Biochemical and biophysical research communications.

Dual Cardiovascular Effects of Endothelin‐1 Dissociated by BQ‐153, a Novel ETA Receptor Antagonist

M. Yano, B. Battistini, I. Rodger, 1994, Journal of cardiovascular pharmacology.

In Vitro Biological Profile of a Highly Potent Novel Endothelin (ET) Antagonist BQ‐123 Selective for the ETA Receptor

T. Fukami, M. Yano, T. Saeki, 1992, Journal of cardiovascular pharmacology.

A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs.

M. Yano, T. Sasaki, K. Ishikawa, 1993, Biochemical and biophysical research communications.

[Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity.

M. Yano, T. Saeki, T. Fukuroda, 1991, Biochemical and biophysical research communications.

[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.

S. Ozaki, T. Fukami, M. Yano, 1995, European journal of pharmacology.

6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives: a novel class of endothelin receptor antagonists.

T. Hayama, S. Ito, S. Ozaki, 2002, Bioorganic & medicinal chemistry.

An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.

M. Yano, T. Saeki, T. Fukuroda, 1991, Biochemical and biophysical research communications.

Enhancement by endothelin‐1 of microvascular permeability via the activation of ETA receptors

G. Plante, A. Fournier, M. Sirois, 1993, British journal of pharmacology.

Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat

T. Warner, M. Yano, A. Claing, 1993, British journal of pharmacology.

Characterization of Receptors for Endothelins in the Guinea Pig Mesenteric Vasculature

M. Yano, A. Claing, P. D'Orléans-Juste, 1995, Journal of cardiovascular pharmacology.

The in vivo antiaggregatory action of endothelin-1 is not mediated through the endothelin ETA receptor.

J. Filep, M. Yano, F. Hermán, 1993, European journal of pharmacology.

Human big‐endothelin‐1 and endothelin‐1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung

M. Yano, A. Claing, P. D'Orléans-Juste, 1992, British journal of pharmacology.

ETA-dependent pressor effects and release of prostacyclin induced by endothelins in pulmonary and renal vasculature.

M. Yano, P. D'Orléans-Juste, S. Télémaque, 1993, Journal of cardiovascular pharmacology.

Endothelin Receptor Subtypes in Porcine Tissues

M. Yano, T. Saeki, M. Ihara, 1990 .

Biochemical and pharmacological profile of a potent and selective endothelin

S. Ozaki, T. Fukami, M. Yano, 2022 .

Radioimmunoassay for clebopride, a new benzamide drug with antidopaminergic activity.

T. Fukami, M. Yano, K. Ishikawa, 1984, Chemical & pharmaceutical bulletin.

[Preventive effect of KZ-1026 on acute liver injury induced by CCl4 in rats: histochemical, enzyme-histochemical and ultrastructural studies].

T. Uchida, M. Yano, T. Takahashi, 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[Phe22]-Big Endothelin‐1 [19–37]: A New and Potent Inhibitor of the Endothelin‐Converting Enzyme

M. Yano, W. Neugebauer, A. Claing, 1995, Journal of cardiovascular pharmacology.

Relationship between endothelin and thromboxane A2 in rat liver microcirculation.

T. Kurihara, M. Yano, Y. Hirayama, 1992, Life sciences.

Cardiovascular and renal actions of the endothelin(B) receptor in pigs.

E. Martin, M. Yano, I. Rodger, 1997, Journal of cardiovascular pharmacology.